Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2024
August 09, 2024 15:11 ET
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Cell Therapy Biomanufacturing Market Report 2024: Market Revenue Data from 2022, Estimates for 2023, Forecasts for 2024 and Projected CAGRs through 2029
August 09, 2024 05:41 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Biomanufacturing Market 2024-2029" report has been added to ResearchAndMarkets.com's offering. The cell therapy biomanufacturing global...
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024 08:00 ET
|
Phathom Pharmaceuticals
Over 122,000 prescriptions for VOQUEZNA® products written by healthcare providers, launch to date, a 184% increase since last quarterly reportNet revenues of $7.3 million reported for the second...
Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
August 07, 2024 07:00 ET
|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
World’s largest packaging and processing event has selected unique bible paper product as a finalist for the 2024 Technology Excellence Awards – the only European company in the category
August 07, 2024 01:23 ET
|
ThinPrinting by St Michel Print
Pack Expo International has selected Unique medical leaflet - Thin Bible Paper Booklet as a finalist for the 2024 Technology Excellence Awards.
Pharmaceutical Industry Net Zero Strategies Thematic Intelligence Report: Reduction Targets, Data, and Strategies of 18 Leading Pharmaceutical Companies
August 06, 2024 10:11 ET
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector" report has been added to ResearchAndMarkets.com's offering. This report...
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
August 01, 2024 16:05 ET
|
Lumos Pharma, Inc.
Following Positive End of Phase 2 Meeting with FDA, Company Continues to Advance Plans for Phase 3 Placebo-Controlled Trial of LUM-201 in Moderate Pediatric Growth Hormone Deficiency Expects to...
Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation
July 31, 2024 07:30 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 12th annual Regeneron Prize for Creative Innovation (the...
MannKind Corporation to Hold 2024 Second Quarter Financial Results Conference Call on August 7, 2024
July 30, 2024 16:30 ET
|
MannKind
MANNKIND CORPORATION TO HOLD 2024 SECOND QUARTER FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 7, 2024
Marius Pharmaceuticals Submits KYZATREX® (Testosterone Undecanoate) CIII Capsules for Approval to Health Canada
July 30, 2024 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on developing innovative therapies for Testosterone Deficiency, is pleased to...